Breast Cancer Res Treat. In some cases, DCIS may become invasive and spread to other tissues, but there is no way of determining which lesions will remain stable without treatment, and which will go on to become invasive. Our data suggest that physicians are more successful at conveying the risks conferred by DCIS than the nuances of DCIS as a non-life-threatening diagnosis. Was this article helpful? Blythe; Benard, Vicki B.
|Published (Last):||27 May 2010|
|PDF File Size:||11.40 Mb|
|ePub File Size:||9.98 Mb|
|Price:||Free* [*Free Regsitration Required]|
Ductal means that the cancer starts inside the milk ducts, carcinoma refers to any cancer that begins in the skin or other tissues including breast tissue that cover or line the internal organs, and in situ means "in its original place. When you have had DCIS, you are at higher risk for the cancer coming back or for developing a new breast cancer than a person who has never had breast cancer before. Most recurrences happen within the 5 to 10 years after initial diagnosis. Learn what additional steps you can take to lower your risk of a new breast cancer diagnosis or a recurrence in the Lower Your Risk section.
If breast cancer does come back after earlier DCIS treatment, the recurrence is non-invasive DCIS again about half the time and invasive about half the time. According to the American Cancer Society, about 60, cases of DCIS are diagnosed in the United States each year, accounting for about 1 out of every 5 new breast cancer cases. There are two main reasons this number is so large and has been increasing over time: People are living much longer lives.
As we grow older, our risk of breast cancer increases. More people are getting mammograms, and the quality of the mammograms has improved. With better screening, more cancers are being spotted early. On the following pages you can learn about:.
Ductal Carcinoma In Situ (DCIS)
Currently, all DCIS lesions are treated, and treatment comprises either mastectomy or breast-conserving surgery supplemented with radiotherapy. However, most DCIS lesions remain indolent. Difficulty in discerning harmless lesions from potentially invasive ones can lead to overtreatment of this condition in many patients. To counter overtreatment and to transform clinical practice, a global, comprehensive and multidisciplinary collaboration is required.
Ductal carcinoma in situ: to treat or not to treat, that is the question
INTRADUCTAL CARCINOMA IN SITU BREAST FILETYPE PDF